Evidence map›Paper›PMID 24006450›Full record

ArticleCirculation. Arrhythmia and electrophysiology2013

Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.

Courtney M Campbell, Jonathan D Campbell, Christopher H Thompson, Eleonora Savio Galimberti, Dawood Darbar, Carlos G Vanoye, Alfred L George

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Arrhythmia and electrophysiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Structural interplay of KHeartRhythm case reports · 2016
    Article
  10. Genotype influence in responses to therapy for atrial fibrillation.Expert review of cardiovascular therapy · 2016
    Review
  11. Atrial fibrillation.Nature reviews. Disease primers · 2016
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Courtney M CampbellDepartment of Pharmacology and Department of Medicine, Vanderbilt University, Nashville, TN; and Department of Engineering Management, Information, and Systems, Southern Methodist University, Dallas, TX.
Jonathan D Campbell
Christopher H Thompson
Eleonora Savio Galimberti
Dawood Darbar
Carlos G Vanoye
Alfred L George
Southern Methodist University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
Positional Cloning and Candidate Gene Approach to Familial Atrial FibrillationR01HL092217 · NHLBI · VANDERBILT UNIVERSITY · PI DARBAR, DAWOOD · 2009 to 2017
$2.9M
Mechanism of Atrial Fibrillation Susceptibility Due to Mutant Potassium ChannelsF30HL107066 · NHLBI · VANDERBILT UNIVERSITY · PI CAMPBELL, COURTNEY MICHELLE · 2011 to 2015
$128k
NHLBI NIH HHS F30 HL107066NHLBI NIH HHS HL092217NHLBI NIH HHS R01 HL092217NHLBI NIH HHS U19 HL065962NHLBI NIH HHS U19-HL65962-10NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM07347NIMH NIH HHS T32 MH065215
6 · The paper itself

Abstract

backgroundAtrial fibrillation is the most common sustained cardiac arrhythmia in adults. We hypothesized that gain-of-function KCNQ1 mutations previously associated with familial atrial fibrillation have distinct pharmacological properties that may enable targeted inhibition. METHODS AND

resultsWild-type (WT) KCNQ1 or the familial atrial fibrillation mutation KCNQ1-S140G was heterologously coexpressed with KCNE1 to enable electrophysiological recording of the slow delayed rectifier current (IKs) and investigation of pharmacological effects of the IKs selective blocker HMR-1556. Coexpression of KCNQ1-S140G with KCNE1 generated potassium currents (S140G-IKs) that exhibited greater sensitivity to HMR-1556 than WT-IKs. Enhanced HMR-1556 sensitivity was also observed for another gain-of-function atrial fibrillation mutation, KCNQ1-V141M. Heteromeric expression of KCNE1 with both KCNQ1-WT and KCNQ1-S140G generated currents (HET-IKs) with gain-of-function features, including larger amplitude, a constitutively active component, hyperpolarized voltage dependence of activation, and extremely slow deactivation. A low concentration of HMR-1556, which had little effect on WT-IKs but was capable of inhibiting the mutant channel, reduced both instantaneous and steady state HET-IKs to levels that were not significantly different from WT-IKs and attenuated use-dependent accumulation of the current. In cultured adult rabbit left atrial myocytes, expression of S140G-IKs shortened action potential duration compared with WT-IKs. Application of HMR-1556 mitigated S140G-IKs-induced action potential duration shortening and did not alter action potential duration in cells expressing WT-IKs.

conclusionsThe enhanced sensitivity of KCNQ1 gain-of-function mutations for HMR-1556 suggests the possibility of selective therapeutic targeting, and, therefore, our data illustrate a potential proof of principle for genotype-specific treatment of this heritable arrhythmia.

Indexed as

MutationAnimalsAtrial FibrillationCells, CulturedChromansCricetulusGenetic Predisposition to DiseaseKCNQ1 Potassium ChannelMyocytes, CardiacPatch-Clamp TechniquesPlasmidsPotassium Channels, Voltage-GatedRabbitsRisk FactorsSulfonamidesChromansHMR 1556KCNQ1 Potassium ChannelPotassium Channels, Voltage-GatedSulfonamidesantiarrhythmic drugsarrhythmias, cardiacatrial fibrillationgeneticspotassium channels

Identifiers

PMID24006450
PMCPMC3892565
OpenAlexW2162445663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.